Arsenal Biosciences, Inc. (ArsenalBio), a clinical stage programmable cell therapy company focused on engineering advanced CAR T-cell therapies for solid tumors, announced the close...
LumaCyte, a leader in advanced cellular analysis and precision bioanalytics, proudly announces the launch of its groundbreaking cell therapy application for predictive CAR T...
Rigaku Corporation, a Rigaku Holdings Group company and global partner for lab-to-factory X-ray analysis, has developed a patent-pending technology called Electron Density Topography (EDT)....
Amphista Therapeutics, a leader in next generation targeted protein degradation (TPD) approaches, announces the appointment of Antony Mattessich as its Chief Executive Officer (CEO)...
Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...
